Provided by Tiger Trade Technology Pte. Ltd.

Bruker

53.42
-1.0100-1.86%
Volume:1.11M
Turnover:59.25M
Market Cap:8.13B
PE:-76.01
High:54.31
Open:53.21
Low:52.58
Close:54.43
52wk High:65.30
52wk Low:30.09
Shares:152.23M
Float Shares:103.69M
Volume Ratio:0.97
T/O Rate:1.07%
Dividend:0.20
Dividend Rate:0.37%
EPS(TTM):-0.7028
EPS(LYR):-0.1500
ROE:-3.00%
ROA:3.14%
PB:3.41
PE(LYR):-356.13

Loading ...

Movement Alert|Bruker Falls 6.22% in Regular Trading, Trading at $54.72

Market Focus
·
Yesterday

UBS Adjusts Bruker Price Target to $65 From $45, Maintains Neutral Rating

MT Newswires Live
·
Sep 09

U.S. Research Roundup-Argan, Mastec, Oracle

Reuters
·
Sep 09

Bruker Leadership Presents at Upcoming Wells Fargo Healthcare Conference

Reuters
·
Sep 09

Bruker Announces BRL 0.02 Dividend Per Unit for Q3 2026

Reuters
·
Sep 05

Bruker BEST, Luvata Enter Strategic Collaboration to Supply RRP Superconductors for Fusion Magnets

Reuters
·
Sep 04

Best and Luvata Announce Collaboration Agreement for Supply of High-Performance Rrp® Superconductors for Magnetic Confinement Fusion

THOMSON REUTERS
·
Sep 04

Bruker’s Q2 Revenue Miss and Softer Outlook Might Change The Case For Investing In Bruker (BRKR)

Simply Wall St.
·
Sep 02

Is Bruker’s (BRKR) AI Bet With Atinary Quietly Redefining Its Long-Term R&D Strategy?

Simply Wall St.
·
Aug 24

Bruker Nano EVP, President Mark Munch Disposes of 4,984 Bruker Shares for $288,636.8

Reuters
·
Aug 19

Bruker Board Declares Quarterly Cash Dividend for Shareholders

TIPRANKS
·
Aug 15

Bruker Declares Quarterly Cash Dividend of $0.05 a Share

Reuters
·
Aug 15

Bruker Expands Atinary Collaboration, Makes Minority Investment in AI R&D Firm

MT Newswires Live
·
Aug 11

Bruker announces strategic collaboration with Atinary Technologies

TIPRANKS
·
Aug 11

Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories

THOMSON REUTERS
·
Aug 11

Bruker Corporation - Makes Minority Investment in Atinary; Financial Details not Disclosed

THOMSON REUTERS
·
Aug 11

Bruker (BRKR) Could Be 6% Undervalued After Quarterly Loss And 2026 Guidance

Simply Wall St.
·
Aug 11

Bruker Takes Majority Stake in Organ-on-a-Chip Developer Mimetas

Reuters
·
Aug 10

Bruker Announces Majority Investment in Mimetas to Advance Human Physiology-Relevant Drug Discovery and Development

THOMSON REUTERS
·
Aug 10

Bruker Corporation - Financial Details not Disclosed; Mimetas to Operate Under Existing Brand and Management

THOMSON REUTERS
·
Aug 10